Zürcher Nachrichten - Mice trial raises hopes for 'on demand' male contraceptive

EUR -
AED 4.02547
AFN 78.958383
ALL 99.102869
AMD 431.181955
ANG 1.961978
AOA 1003.890567
ARS 1184.765046
AUD 1.813586
AWG 1.97271
AZN 1.867466
BAM 1.955265
BBD 2.22659
BDT 133.983319
BGN 1.957778
BHD 0.412787
BIF 3277.602688
BMD 1.09595
BND 1.474296
BOB 7.619914
BRL 6.405394
BSD 1.102698
BTN 94.079244
BWP 15.358795
BYN 3.608812
BYR 21480.619234
BZD 2.215094
CAD 1.559263
CDF 3148.664634
CHF 0.944431
CLF 0.02729
CLP 1047.223301
CNY 7.980215
CNH 7.994999
COP 4582.945323
CRC 557.847278
CUC 1.09595
CUP 29.042674
CVE 110.234821
CZK 25.256829
DJF 196.376238
DKK 7.461451
DOP 69.640934
DZD 146.03502
EGP 55.406831
ERN 16.439249
ETB 145.347308
FJD 2.537019
FKP 0.847795
GBP 0.850992
GEL 3.01429
GGP 0.847795
GHS 17.092321
GIP 0.847795
GMD 78.364643
GNF 9543.387299
GTQ 8.51067
GYD 230.706839
HKD 8.520518
HNL 28.214276
HRK 7.531044
HTG 144.290497
HUF 405.95125
IDR 18351.682095
ILS 4.102536
IMP 0.847795
INR 93.739724
IQD 1444.604509
IRR 46139.49374
ISK 144.852129
JEP 0.847795
JMD 173.912388
JOD 0.776923
JPY 161.033451
KES 142.530979
KGS 95.094267
KHR 4414.791359
KMF 493.729615
KPW 986.361205
KRW 1599.550347
KWD 0.337323
KYD 0.918948
KZT 559.11693
LAK 23885.460858
LBP 98806.249733
LKR 326.960488
LRD 220.54962
LSL 21.028443
LTL 3.236056
LVL 0.66293
LYD 5.33354
MAD 10.502325
MDL 19.485665
MGA 5113.600046
MKD 61.518158
MMK 2300.919896
MNT 3846.361639
MOP 8.828083
MRU 43.97796
MUR 48.956499
MVR 16.881727
MWK 1912.176502
MXN 22.397605
MYR 4.862772
MZN 70.042575
NAD 21.028443
NGN 1679.894432
NIO 40.578891
NOK 11.801632
NPR 150.52679
NZD 1.958628
OMR 0.421635
PAB 1.102798
PEN 4.052091
PGK 4.551754
PHP 62.891131
PKR 309.568949
PLN 4.273706
PYG 8840.579707
QAR 4.019799
RON 4.977847
RSD 117.117937
RUB 92.974546
RWF 1589.164933
SAR 4.112539
SBD 9.114284
SCR 15.716697
SDG 658.12198
SEK 10.951065
SGD 1.474715
SHP 0.861245
SLE 24.933268
SLL 22981.523891
SOS 630.227462
SRD 40.162734
STD 22683.951476
SVC 9.649358
SYP 14249.994157
SZL 21.036241
THB 37.713872
TJS 12.003414
TMT 3.835825
TND 3.376876
TOP 2.566829
TRY 41.607525
TTD 7.469955
TWD 36.360884
TZS 2949.992378
UAH 45.388374
UGX 4030.896458
USD 1.09595
UYU 46.647229
UZS 14248.099286
VES 76.89351
VND 28280.988741
VUV 134.896075
WST 3.078778
XAF 655.777467
XAG 0.037037
XAU 0.000361
XCD 2.96186
XDR 0.815577
XOF 655.777467
XPF 119.331742
YER 269.220506
ZAR 20.960317
ZMK 9864.868719
ZMW 30.57363
ZWL 352.89544
  • RBGPF

    69.0200

    69.02

    +100%

  • SCS

    -0.0600

    10.68

    -0.56%

  • VOD

    -0.8700

    8.5

    -10.24%

  • RELX

    -3.2800

    48.16

    -6.81%

  • RYCEF

    -1.5500

    8.25

    -18.79%

  • NGG

    -3.4600

    65.93

    -5.25%

  • CMSC

    0.0300

    22.29

    +0.13%

  • BTI

    -2.0600

    39.86

    -5.17%

  • CMSD

    0.1600

    22.83

    +0.7%

  • GSK

    -2.4800

    36.53

    -6.79%

  • RIO

    -3.7600

    54.67

    -6.88%

  • JRI

    -0.8600

    11.96

    -7.19%

  • BCE

    0.0500

    22.71

    +0.22%

  • BCC

    0.8100

    95.44

    +0.85%

  • AZN

    -5.4600

    68.46

    -7.98%

  • BP

    -2.9600

    28.38

    -10.43%

Mice trial raises hopes for 'on demand' male contraceptive
Mice trial raises hopes for 'on demand' male contraceptive / Photo: PETER PARKS - AFP/File

Mice trial raises hopes for 'on demand' male contraceptive

If women have the "morning after" pill, could men one day have an "hour before" pill?

Text size:

A new drug candidate renders male mice infertile within an hour and wears off in less than a day, an experimental study said Tuesday, potentially pointing towards a future "on-demand" male contraceptive.

The potential drug, which has not been tested in humans and remains years away from possibly becoming available, joins a growing number of male contraceptives in development.

However there are currently only two options available for men: condoms and vasectomies.

Previous drugs have struggled partly because the bar for side effects is believed to be far higher for men -- because they do not risk getting pregnant -- as well as a lack of interest from the pharmaceutical industry.

"For women, right now all the burden of contraception is on us," Melanie Balbach, a pharmacology researcher at Weill Cornell Medicine in the US, told AFP.

"We want new options," said Balbach, the lead author of the study published in Nature Communications.

The team of researchers targeted an enzyme called soluble adenylyl cyclase, which acts as the "on switch" for sperm, said study co-author Jochen Buck, also of Weill Cornell Medicine.

If the enzyme is switched off, the sperm can no longer move, he said.

Across several different tests, the researchers showed that a compound which blocks the enzyme renders mice sperm immobile in 30 minutes to an hour.

The compound was 100 percent effective in preventing pregnancy within the first two hours, dropping to 91 percent in the first three hours, the study said.

After 24 hours, the mice sperm moved like normal again.

- 'Eye-catching advantage' -

The researchers hope are aiming for a single non-hormonal pill that works in under an hour and lasts six to 12 hours, Buck said.

This would be much different to other options under development, such as a hormonal gel currently going through human trials, which all take weeks or months to start and stop working.

No side effects were noticed in the mice. Previous research has suggested that infertile men who had their soluble adenylyl cyclase enzyme permanently switched off had an increased rate of kidney stones.

Buck said this was the result of their enzyme always being off -- which would not be the case for men taking an on demand pill.

The researchers hope to hold the first trials on humans within three years, with a final product possibly up to eight years away, Buck said.

Susan Walker, an expert in contraception at the UK's Anglia Ruskin University not involved in the research, said she was a "little sceptical" a pill would actually make it to market as so many other efforts have fallen short.

But the "eye-catching advantage" of almost immediate effectiveness offered "the possibility of seeing a sexual partner take a pill," she said.

The consultancy Desire Line is working on forecasting the potential uptake of a range of male contraceptive products, according to its founder Steve Kretschmer.

"Initial estimates indicate in the United States that uptake for an on-demand pill which has quick onset of action and 1-2 days duration of action could be about triple that of Viagra when it was initially launched," he told AFP.

N.Zaugg--NZN